These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29888773)

  • 1. Improving metabolome coverage and data quality: advancing metabolomics and lipidomics for biomarker discovery.
    Vuckovic D
    Chem Commun (Camb); 2018 Jun; 54(50):6728-6749. PubMed ID: 29888773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry.
    Vuckovic D
    Anal Bioanal Chem; 2012 Jun; 403(6):1523-48. PubMed ID: 22576654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming Sample Matrix Effect in Quantitative Blood Metabolomics Using Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry.
    Chen D; Han W; Su X; Li L; Li L
    Anal Chem; 2017 Sep; 89(17):9424-9431. PubMed ID: 28787119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous metabolomics and lipidomics analysis based on novel heart-cutting two-dimensional liquid chromatography-mass spectrometry.
    Wang S; Zhou L; Wang Z; Shi X; Xu G
    Anal Chim Acta; 2017 May; 966():34-40. PubMed ID: 28372724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics Toward Biomarker Discovery.
    Yin P; Xu G
    Methods Mol Biol; 2017; 1619():467-475. PubMed ID: 28674904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
    Lindahl A; Forshed J; Nordström A
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG; Theodoridis GA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in metabolite profiles caused by pre-analytical blood processing procedures.
    Nishiumi S; Suzuki M; Kobayashi T; Yoshida M
    J Biosci Bioeng; 2018 May; 125(5):613-618. PubMed ID: 29258730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
    Shen W; Han W; Li Y; Meng Z; Cai L; Li L
    Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and Study Design Considerations for Uncovering Oncometabolites.
    Haznadar M; Mathé EA
    Methods Mol Biol; 2017; 1513():37-47. PubMed ID: 27807829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
    Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
    Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of coverage, retention patterns, and selectivity of seven liquid chromatographic methods for metabolomics.
    Wernisch S; Pennathur S
    Anal Bioanal Chem; 2016 Sep; 408(22):6079-91. PubMed ID: 27370688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fourier transform mass spectrometry for metabolome analysis.
    Junot C; Madalinski G; Tabet JC; Ezan E
    Analyst; 2010 Sep; 135(9):2203-19. PubMed ID: 20574587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in mass spectrometry based targeted metabolomics.
    Koal T; Deigner HP
    Curr Mol Med; 2010 Mar; 10(2):216-26. PubMed ID: 20196726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain.
    Abbiss H; Gummer JPA; Francki M; Trengove RD
    J Vis Exp; 2020 Mar; (157):. PubMed ID: 32225158
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.